Clinical Trial Update: Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adalimumab in combination with methotrexate versus methotrexate alone in early rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED